BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 20308669)

  • 21. Systemic levels of neuropeptide Y and dipeptidyl peptidase activity in patients with Ewing sarcoma--associations with tumor phenotype and survival.
    Tilan JU; Krailo M; Barkauskas DA; Galli S; Mtaweh H; Long J; Wang H; Hawkins K; Lu C; Jeha D; Izycka-Swieszewska E; Lawlor ER; Toretsky JA; Kitlinska JB
    Cancer; 2015 Mar; 121(5):697-707. PubMed ID: 25387699
    [TBL] [Abstract][Full Text] [Related]  

  • 22. EWS-FLI1 in Ewing's sarcoma: real targets and collateral damage.
    Ban J; Siligan C; Kreppel M; Aryee D; Kovar H
    Adv Exp Med Biol; 2006; 587():41-52. PubMed ID: 17163154
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Absence of detectable EWS/FLI1 expression after therapy-induced neural differentiation in Ewing sarcoma.
    Knezevich SR; Hendson G; Mathers JA; Carpenter B; Lopez-Terrada D; Brown KL; Sorensen PH
    Hum Pathol; 1998 Mar; 29(3):289-94. PubMed ID: 9496833
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MiR-30a-5p connects EWS-FLI1 and CD99, two major therapeutic targets in Ewing tumor.
    Franzetti GA; Laud-Duval K; Bellanger D; Stern MH; Sastre-Garau X; Delattre O
    Oncogene; 2013 Aug; 32(33):3915-21. PubMed ID: 22986530
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinicopathological and molecular spectrum of ewing sarcomas/PNETs, including validation of EWSR1 rearrangement by conventional and array FISH technique in certain cases.
    Rekhi B; Vogel U; Basak R; Desai SB; Jambhekar NA
    Pathol Oncol Res; 2014 Jul; 20(3):503-16. PubMed ID: 24293381
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpression of HOX genes is prevalent in Ewing sarcoma and is associated with altered epigenetic regulation of developmental transcription programs.
    Svoboda LK; Harris A; Bailey NJ; Schwentner R; Tomazou E; von Levetzow C; Magnuson B; Ljungman M; Kovar H; Lawlor ER
    Epigenetics; 2014 Dec; 9(12):1613-25. PubMed ID: 25625846
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting the epigenetic readers in Ewing sarcoma inhibits the oncogenic transcription factor EWS/Fli1.
    Jacques C; Lamoureux F; Baud'huin M; Rodriguez Calleja L; Quillard T; Amiaud J; Tirode F; Rédini F; Bradner JE; Heymann D; Ory B
    Oncotarget; 2016 Apr; 7(17):24125-40. PubMed ID: 27006472
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of various exon combinations of the ews/fli1 translocation: an optimized RT-PCR method for paraffin embedded tissue -- a report by the CWS-study group.
    Stegmaier S; Leuschner I; Aakcha-Rudel E; Münch P; Kazanowska B; Bekassy A; Treuner J; Koscielniak E
    Klin Padiatr; 2004; 216(6):315-22. PubMed ID: 15565546
    [TBL] [Abstract][Full Text] [Related]  

  • 29. STAT3 is activated in a subset of the Ewing sarcoma family of tumours.
    Lai R; Navid F; Rodriguez-Galindo C; Liu T; Fuller CE; Ganti R; Dien J; Dalton J; Billups C; Khoury JD
    J Pathol; 2006 Apr; 208(5):624-32. PubMed ID: 16463269
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting the EWS-ETS transcriptional program by BET bromodomain inhibition in Ewing sarcoma.
    Hensel T; Giorgi C; Schmidt O; Calzada-Wack J; Neff F; Buch T; Niggli FK; Schäfer BW; Burdach S; Richter GH
    Oncotarget; 2016 Jan; 7(2):1451-63. PubMed ID: 26623725
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The orphan nuclear receptor DAX1 is up-regulated by the EWS/FLI1 oncoprotein and is highly expressed in Ewing tumors.
    Mendiola M; Carrillo J; García E; Lalli E; Hernández T; de Alava E; Tirode F; Delattre O; García-Miguel P; López-Barea F; Pestaña A; Alonso J
    Int J Cancer; 2006 Mar; 118(6):1381-9. PubMed ID: 16206264
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relation of neurological marker expression and EWS gene fusion types in MIC2/CD99-positive tumors of the Ewing family.
    Amann G; Zoubek A; Salzer-Kuntschik M; Windhager R; Kovar H
    Hum Pathol; 1999 Sep; 30(9):1058-64. PubMed ID: 10492040
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does expression of different EWS chimeric transcripts define clinically distinct risk groups of Ewing tumor patients?
    Zoubek A; Dockhorn-Dworniczak B; Delattre O; Christiansen H; Niggli F; Gatterer-Menz I; Smith TL; Jürgens H; Gadner H; Kovar H
    J Clin Oncol; 1996 Apr; 14(4):1245-51. PubMed ID: 8648380
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proteasomal Degradation of the EWS-FLI1 Fusion Protein Is Regulated by a Single Lysine Residue.
    Gierisch ME; Pfistner F; Lopez-Garcia LA; Harder L; Schäfer BW; Niggli FK
    J Biol Chem; 2016 Dec; 291(52):26922-26933. PubMed ID: 27875302
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genomic EWS-FLI1 fusion sequences in Ewing sarcoma resemble breakpoint characteristics of immature lymphoid malignancies.
    Berger M; Dirksen U; Braeuninger A; Koehler G; Juergens H; Krumbholz M; Metzler M
    PLoS One; 2013; 8(2):e56408. PubMed ID: 23441188
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD99 positivity and EWS-FLI1 gene rearrangement identify a breast tumor in a 60-year-old patient with attributes of the Ewing family of neoplasms.
    Sezer O; Jugovic D; Blohmer JU; Turzynski A; Thiel G; Langelotz C; Possinger K; Kovar H
    Diagn Mol Pathol; 1999 Sep; 8(3):120-4. PubMed ID: 10565682
    [TBL] [Abstract][Full Text] [Related]  

  • 37. EWS/FLI-1 fusion signal inserted into chromosome 11 in one patient with morphologic features of Ewing sarcoma, but lacking t(11;22).
    Batanian JR; Bridge JA; Wickert R; Vogler C; Gadre B; Huang Y
    Cancer Genet Cytogenet; 2002 Feb; 133(1):72-5. PubMed ID: 11890993
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence of neural differentiation in a case of post-therapy primitive neuroectodermal tumor/Ewing sarcoma of bone.
    Collini P; Mezzelani A; Modena P; Dagrada P; Tamborini E; Luksch R; Gronchi A; Navarria P; Sozzi G; Pilotti S
    Am J Surg Pathol; 2003 Aug; 27(8):1161-6. PubMed ID: 12883251
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of fusion subtype in Ewing sarcoma.
    Barr FG; Meyer WH
    J Clin Oncol; 2010 Apr; 28(12):1973-4. PubMed ID: 20308653
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparative analysis of routine histology, immunohistochemistry, reverse transcriptase polymerase chain reaction, and fluorescence in situ hybridization in diagnosis of Ewing family of tumors.
    Jambhekar NA; Bagwan IN; Ghule P; Shet TM; Chinoy RF; Agarwal S; Joshi R; Amare Kadam PS
    Arch Pathol Lab Med; 2006 Dec; 130(12):1813-8. PubMed ID: 17149955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.